2013
DOI: 10.1038/ejhg.2012.298
|View full text |Cite
|
Sign up to set email alerts
|

Clinical utility gene card for: poikiloderma with neutropenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 18 publications
0
6
0
Order By: Relevance
“…PN has two hallmarks: “poikiloderma” and mild to severe “neutropenia”. The latter predisposes to myelodysplasia and acute myeloid leukaemia 3 4 5 6 12 13 thus featuring PN as a disorder of the haematopoietic cascade, mainly of the myeloid lineage. Biochemical studies on yeast and lymphoblastoid cells from PN patients have shown that USB1 plays a crucial role in the stability and recycling of U6 snRNA, a component of the RNA splicing machinery 16 17 18 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…PN has two hallmarks: “poikiloderma” and mild to severe “neutropenia”. The latter predisposes to myelodysplasia and acute myeloid leukaemia 3 4 5 6 12 13 thus featuring PN as a disorder of the haematopoietic cascade, mainly of the myeloid lineage. Biochemical studies on yeast and lymphoblastoid cells from PN patients have shown that USB1 plays a crucial role in the stability and recycling of U6 snRNA, a component of the RNA splicing machinery 16 17 18 .…”
Section: Discussionmentioning
confidence: 99%
“…Discovery of the causative C16orf57 gene by autozygosity mapping and next-generation sequencing of the linkage region on chromosome 16 6 , confirmed that PN is genetically distinct from clinically overlapping entities, in particular Rothmund-Thomson syndrome (OMIM#268400), and allowed the introduction of the genetic test to validate diagnosis and provide patients with the appropriate oncological surveillance 7 8 9 10 11 . Neutropenia, the distinctive PN hallmark, confers on patients a high risk to develop myelodysplasia, often evolving into acute myeloid leukaemia in the second decade of life 12 13 .…”
mentioning
confidence: 99%
“…Before treatment, his length was 132 cm (−3.8 SD) and his final length was 156 cm (−3.5 SD). To our knowledge, this is the first patient that GH therapy is applied for a PN patient [Larizza et al, ]. To demonstrate the effects of the GH therapy, further practices are needed.…”
Section: Discussionmentioning
confidence: 99%
“…2,7 The identification of a molecular anomaly in FAM111B gives definitive proof of POIKTMP and enables its distinction from other types of hereditary poikiloderma, such as RTS (MIM#268400), hereditary sclerosing poikiloderma of Weary (MIM#173700), poikiloderma with neutropenia (PN; MIM#604173) or Kindler syndrome (MIM#173650). 6,[8][9][10][11] Above all, the main differential diagnosis of POIKTMP is RTS as all patients were initially misdiagnosed with RTS in childhood. These two entities share indeed common characteristics, such as early-onset poikiloderma, ectodermal dysplasia features, palmoplantar hyperkeratotic lesions, growth delay.…”
Section: Diagnostic Settingmentioning
confidence: 99%